BGBenjamin Gardner

Benjamin Gardner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benjamin Gardner has a total of 197 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Renally Excretable Gold Nanoparticle Oncology Platform Enabling Effective Photothermal Therapy and Chemotherapy Combination

    by Guojun Xiong, Alexandra Vaideanu, Ryan D. Mellor, Chengwei Jiang, Benjamin Gardner, Nick Stone, Andreas G. Schätzlein, Ijeoma F. Uchegbu

    Combination therapies have largely replaced monotherapies in oncology. Thermal therapy has been developed as an adjunctive treatment owing to its safety and high compatibility with established theraypy options. However, bulky equipment and non-standardized protocols have limited its clinical use. The emergence of gold nanoparticle (AuNP)-based photothermal therapy (PTT) offers a simpler approach using injectable formulations and portable near-infrared (NIR) laser devices. However, poor excretion of AuNPs raises safety concerns and hinders translation. Here, we designed a gold nanoplatform that retains the photothermal capacity of AuNPs while enabling efficient excretion. Ultrasmall AuNPs (p-methoxybenzenethiol (MBT) to stabilize ultrasmall AuNPs, clustered them with poly(lactic-co-glycolic acid) (PLGA), and coated said clusters with acetylated human serum albumin (Ac-HSA). The resulting Ac-HSA-PLGA-AuNCs demonstrated reduced hepatic retention along with renal excretion of ultrasmall gold species. Intratumoral injection followed by 10 min NIR irradiation achieved efficient tumor ablation, outperforming conventional hyperthermia that usually requires hours of heating. Furthermore, combining Ac-HSA-PLGA-AuNC-based PTT with high-dose paclitaxel (160 mg/kg) was safe and yielded enhanced antitumor efficacy. This developed gold nanoplatform offers a promising strategy for translatable PTT-chemotherapy combinations.


  • Open Access

    An All-in-One Nanoheater and Optical Thermometer Fabricated from Fractal Nanoparticle Assemblies

    by William H. Skinner, Renata L. Sala, Kamil Sokolowski, Ioana Blein-Dezayes, Natalie S. Potter, Sara Mosca, Benjamin Gardner, Jeremy J. Baumberg, Pavel Matousek, Oren A. Scherman, et al.

    We designed and optimized a dual-functional photothermal agent that performs as a nanoheater and real-time optical thermometer by leveraging gold nanoparticle (AuNP) self-assembly and anti-Stokes thermometry. We engineered colloidally stable fractal AuNP clusters with well-defined nanogaps to absorb strongly in the near-infrared and enhance anti-Stokes vibrational modes via surface-enhanced Raman scattering (SERS) for electromagnetic (EM) hotspot-localized thermometry during plasmonic heating. Photothermal characterization and simulations of a range of AuNP building block sizes demonstrated that 40 nm AuNPs are optimum for combined plasmonic heating and SERS due to the high probability of in resonance chains within assemblies. We explored the relationship between the far-field of our AuNP clusters and the near-field enhancement of anti-Stokes modes in the context of SERS thermometry, setting out design considerations for applying SERS thermometry. Finally, using a single near-infrared (NIR) laser source, we demonstrated plasmonic heating of a colloidal system with simultaneous accurate temperature measurement from EM hotspots via the thermal information encoded in the anti-Stokes mode of surface-bound Raman reporter molecules. Ultimately, our approach could enable real-time noninvasive temperature feedback from plasmonic nanoparticles within tumor tissue environments to guide safe and effective temperature increases during cancer photothermal therapy.


  • Open Access

    Raman spectroscopy of ovarian and peritoneal tissue in the assessment of ovarian cancer

    by Diana Frimpong, Angela C. Shore, Benjamin Gardner, Claire Newton, Joya Pawade, Jonathan Frost, Laura Atherton, Nick Stone

    We demonstrate that Raman spectroscopy is a viable tool for ovarian cancer assessment.


  • Top Cited Papers

    Surface-Enhanced Raman Spectroscopy for Biomedical Applications: Recent Advances and Future Challenges

    by Linley Li Lin, Ramon Alvarez-Puebla, Luis M. Liz-Marzán, Matt Trau, Jing Wang, Laura Fabris, Xiang Wang, Guokun Liu, Shuping Xu, Xiao Xia Han, et al.

    The year 2024 marks the 50th anniversary of the discovery of surface-enhanced Raman spectroscopy (SERS). Over recent years, SERS has experienced rapid development and became a critical tool in biomedicine with its unparalleled sensitivity and molecular specificity. This review summarizes the advancements and challenges in SERS substrates, nanotags, instrumentation, and spectral analysis for biomedical applications. We highlight the key developments in colloidal and solid SERS substrates, with an emphasis on surface chemistry, hotspot design, and 3D hydrogel plasmonic architectures. Additionally, we introduce recent innovations in SERS nanotags, including those with interior gaps, orthogonal Raman reporters, and near-infrared-II-responsive properties, along with biomimetic coatings. Emerging technologies such as optical tweezers, plasmonic nanopores, and wearable sensors have expanded SERS capabilities for single-cell and single-molecule analysis. Advances in spectral analysis, including signal digitalization, denoising, and deep learning algorithms, have improved the quantification of complex biological data. Finally, this review discusses SERS biomedical applications in nucleic acid detection, protein characterization, metabolite analysis, single-cell monitoring, and in vivo deep Raman spectroscopy, emphasizing its potential for liquid biopsy, metabolic phenotyping, and extracellular vesicle diagnostics. The review concludes with a perspective on clinical translation of SERS, addressing commercialization potentials and the challenges in deep tissue in vivo sensing and imaging.


  • Open Access

    Gold Nanoraspberries for Surface-Enhanced Raman Scattering: Synthesis, Optimization, and Characterization

    by Megha Mehta, William Skinner, Benjamin Gardner, Sara Mosca, Francesca Palombo, Pavel Matousek, Nick Stone

    In this work, we demonstrate the synthesis of gold nanoraspberries (AuNRB) using a HEPES buffer at room temperature. The study aimed to identify and compare the physicochemical conditions of the AuNRB and gold nanospheres (AuNS) of similar size to a selected set of reporter molecules. The dispersion stability of shape-controlled and AuNS of similar diameters was investigated in three different physiological media, ultrapure water, phosphate-buffered saline (PBS), and fetal bovine serum (FBS), and compared to understand the effect of NP shape, dispersion stability, and surface-enhanced Raman scattering (SERS) enhancement. We have used two nonresonant reporters, trans-1,2-bis(4-pyridyl) ethylene (BPE) and biphenyl-4-thiol (BPT), and a resonant reporter, IR820 (also known as new indocyanine green), a clinically approved dye for diagnostic studies, to explore the relative benefit of using molecular electronic resonance, i.e., comparing SERS vs surface-enhanced resonance Raman scattering (SERRS) with these nanoparticles. SERS has been explored extensively for biomedical applications, but the synthesis of bright gold nanoparticles and the appropriate Raman label is still challenging. To understand and optimize the SERS process, we have characterized both types of gold nanoparticles, ranging from their average size, ζ-potential, and ultraviolet-visible (UV-vis) absorption. It has been found that AuNRB and AuNS are most stable when dispersed in ultrapure water, while significant aggregation of both types has been observed when dispersed in PBS. With 10% FBS, there was a slight shift and increase in the surface plasmon absorbance peak, which resulted from an increase in particle size due to protein corona formation around the gold nanoparticles. For SERS efficiency, it has been found that AuNRB outperform AuNS with all reporters. Further, the resonant reporter, IR820, has provided a higher SERS signal compared to BPE and BPT and with its FDA approval for clinical use is clearly a strong candidate for future in vivo application.


  • Open Access

    Plasmonic Nanoparticles for Photothermal Therapy: Benchmarking of Photothermal Properties and Modeling of Heating at Depth in Human Tissues

    by William H. Skinner, Marzieh Salimi, Laura Moran, Ioana Blein-Dezayes, Megha Mehta, Sara Mosca, Alexandra-Geanina Vaideanu, Benjamin Gardner, Francesca Palombo, Andreas G. Schätzlein, et al.

    Many different types of nanoparticles have been developed for photothermal therapy (PTT), but directly comparing their efficacy as heaters and determining how they will perform when localized at depth in tissue remains complex. To choose the optimal nanoparticle for a desired hyperthermic therapy, it is vital to understand how efficiently different nanoparticles extinguish laser light and convert that energy to heat. In this paper, we apply photothermal mass conversion efficiency (η m ) as a metric to compare nanoparticles of different shapes, sizes, and conversion efficiencies. We selected silica-gold nanoshells (AuNShells), gold nanorods (AuNRs), and gold nanostars (AuNStars) as three archetypal nanoparticles for PTT and measured the η m of each to demonstrate the importance of considering both photothermal efficiency and extinction cross section when comparing nanoparticles. By utilizing a Monte Carlo model, we further applied η m to model how AuNRs performed when located at tissue depths of 0-30 mm by simulating the depth penetration of near-infrared (NIR) laser light. These results show how nanoparticle concentration, laser power, and tissue depth influence the ramp time to a hyperthermic temperature of 43 °C. The methodology outlined in this paper creates a framework to benchmark the heating efficacy of different nanoparticle types and a means of estimating the feasibility of nanoparticle-mediated PTT at depth in the NIR window. These are key considerations when predicting the potential clinical impact in the early stages of nanoparticle design.


  • Open Access

    Guided principal component analysis (GPCA): a simple method for improving detection of a known analyte

    by Benjamin Gardner, Jennifer Haskell, Pavel Matousek, Nicholas Stone

    There is increasing interest in the application of Raman spectroscopy in a medical setting, ranging from supporting real-time clinical decisions e.g. surgical margins to assisting pathologists with disease classification. However, there remain a number of barriers for adoption in the medical setting due to the increased complexity of probing highly heterogeneous, dynamic biological materials. This inherent challenge can also limit the deployment of higher level analytical approaches such as Artificial Intelligence (AI) including convolutional neural networks (CNN), as there is a lack of a ground truth required for training purposes i.e. in complex clinical samples. Principal component analysis (PCA) is an unsupervised data reduction approach (orthogonal linear transformation) that has been used extensively in spectroscopy for 30+ years, due to its capability to simplify analysis of complex spectroscopic data. However, due to PCA being unsupervised features will inherently appear mixed and their rank may vary between experiments. Here we propose Guided PCA (GPCA), a simple approach that allows PCA to be guided with spectral data to ensure a consistent rank of a key target moiety by the inclusion of a reference (guiding) spectrum to the data set. This simplifies analysis, increases robustness of PCA analysis and improves quantification and the limits of detection and decreases RMSE.


  • Open Access

    High wavenumber Raman spectroscopy for intraoperative assessment of breast tumour margins

    by Jennifer Maria Haskell, Thomas Hubbard, Claire Murray, Benjamin Gardner, Charlotte Ives, Douglas Ferguson, Nick Stone

    Spectra taken using a HWN Raman probe from bisected mastectomy specimens are capable of identifying tumour versus normal tissue through the difference in water, protein and lipid content.


  • Open Access

    Nanoparticle-Mediated Photothermal Therapy Limitation in Clinical Applications Regarding Pain Management

    by Marzieh Salimi, Sara Mosca, Benjamin Gardner, Francesca Palombo, Pavel Matousek, Nicholas Stone

    The development of new effective cancer treatment methods has attracted much attention, mainly due to the limited efficacy and considerable side effects of currently used cancer treatment methods such as radiation therapy and chemotherapy. Photothermal therapy based on the use of plasmonically resonant metallic nanoparticles has emerged as a promising technique to eradicate cancer cells selectively. In this method, plasmonic nanoparticles are first preferentially uptaken by a tumor and then selectively heated by exposure to laser radiation with a specific plasmonic resonant wavelength, to destroy the tumor whilst minimizing damage to adjacent normal tissue. However, several parameters can limit the effectiveness of photothermal therapy, resulting in insufficient heating and potentially leading to cancer recurrence. One of these parameters is the patient’s pain sensation during the treatment, if this is performed without use of anesthetic. Pain can restrict the level of applicable laser radiation, cause an interruption to the treatment course and, as such, affect its efficacy, as well as leading to a negative patient experience and consequential general population hesitancy to this type of therapy. Since having a comfortable and painless procedure is one of the important treatment goals in the clinic, along with its high effectiveness, and due to the relatively low number of studies devoted to this specific topic, we have compiled this review. Moreover, non-invasive and painless methods for temperature measurement during photothermal therapy (PTT), such as Raman spectroscopy and nanothermometry, will be discussed in the following. Here, we firstly outline the physical phenomena underlying the photothermal therapy, and then discuss studies devoted to photothermal cancer treatment concerning pain management and pathways for improved efficiency of photothermal therapy whilst minimizing pain experienced by the patient.


  • Open Access

    An experimental and numerical modelling investigation of the optical properties of Intralipid using deep Raman spectroscopy

    by Laura J. Moran, Freddy Wordingham, Benjamin Gardner, Nicholas Stone, Tim J. Harries

    In this study, Monte Carlo simulations were created to investigate the distribution of Raman signals in tissue phantoms and to validate the arctk code that was used. The aim was to show our code is capable of replicating experimental results in order to use it to advise similar future studies and to predict the outcomes. The experiment performed to benchmark our code used large volume liquid tissue phantoms to simulate the scattering properties of human tissue. The scattering agent used was Intralipid (IL), of various concentrations, filling a small quartz tank. A thin sample of PTFE was made to act as a distinct layer in the tank; this was our Raman signal source. We studied experimentally, and then reproduced via simulations, the variation in Raman signal strength in a transmission geometry as a function of the optical properties of the scattering agent and the location of the Raman material in the volume. We have also found that a direct linear extrapolation of scattering coefficients between concentrations of Intralipid is an incorrect assumption at lower concentrations when determining the optical properties. By combining experimental and simulation results, we have calculated different estimates of these scattering coefficients. The results of this study give insight into light propagation and Raman transport in scattering media and show how the location of maximum Raman signal varies as the optical properties change. The success of arctk in reproducing observed experimental signal behaviour will allow us in future to inform the development of noninvasive cancer screening applications (such as breast and prostate cancers) in vivo.